N-Acetyl Selank Amidate Research for Anxiety
An evidence-based overview of research examining N-Acetyl Selank Amidate in the context of anxiety. This page synthesizes findings from peer-reviewed literature.
Research Summary
The parent compound Selank has been studied for anxiety in Russian clinical trials. Zozulia et al. (2008) reported anxiolytic effects in GAD patients. However, no studies exist on N-Acetyl Selank Amidate specifically. All evidence is extrapolated from the parent compound.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Anxiety
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. N-Acetyl Selank Amidate has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.